Posted Oct. 9, 2013 at 8:37 a.m.

Premium Lock BioDelivery Sciences' opioid treatment could win FDA approval in '14

Published: 2013-10-09 08:37:44
Updated: 2013-10-09 08:37:44

How BDSI technology works How BDSI technology works Image 1 of 2 · Next Image…

The Raleigh-based drug delivery technology firm projects sales of up to $250 million if the opioid dependence treatment wins FDA approval next year....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll